Systemic Treatments and Molecular Biomarkers for Perivascular Epithelioid Cell Tumors: A Single-institution Retrospective Analysis.

Cancer Res Commun · 2023 · PMC10335919 · PMID 37448552

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a nonsignificant trendno p-value reported

There was a nonsignificant trend for shorter median first-line cPFS in those with TP53 mutations (9.4 months, 95% CI: 8.9–not reached) compared with those without (92.4 months, 95% CI: 15.8–not reached, P = 0.09; Fig. 2D ).

also in 5,406 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.